These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12880963)

  • 41. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
    Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
    Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
    Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
    Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.
    Aldosari N; Wiltshire RN; Dutra A; Schrock E; McLendon RE; Friedman HS; Bigner DD; Bigner SH
    Neuro Oncol; 2002 Apr; 4(2):75-85. PubMed ID: 11916498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
    Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
    J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
    O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
    Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Event-free survival in neuroblastoma with MYCN amplification and deletion of 1p or 11q may be associated with altered immune status.
    Wei Z; Gong B; Li X; Chen C; Zhao Q
    BMC Cancer; 2024 Oct; 24(1):1279. PubMed ID: 39407175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The neuroblastoma, "enfant terrible" among pediatric tumors].
    Laureys G
    Verh K Acad Geneeskd Belg; 2003; 65(1):5-23; discussion 23-8. PubMed ID: 12802894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines.
    Van Roy N; Van Limbergen H; Vandesompele J; Van Gele M; Poppe B; Salwen H; Laureys G; Manoel N; De Paepe A; Speleman F
    Genes Chromosomes Cancer; 2001 Oct; 32(2):126-35. PubMed ID: 11550280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.
    Passariello A; De Brasi D; Defferrari R; Genesio R; Tufano M; Mazzocco K; Capasso M; Migliorati R; Martinsson T; Siani P; Nitsch L; Tonini GP
    Eur J Med Genet; 2013 Nov; 56(11):626-34. PubMed ID: 24035971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.
    Lastowska M; Cullinane C; Variend S; Cotterill S; Bown N; O'Neill S; Mazzocco K; Roberts P; Nicholson J; Ellershaw C; Pearson AD; Jackson MS;
    J Clin Oncol; 2001 Jun; 19(12):3080-90. PubMed ID: 11408505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Detection of Genetic Parameters for Prognostic Stratification of Neuroblastoma Using Multiplex Ligation-Dependent Probe Amplification Technique.
    Tumer S; Altungoz O; Bagci O; Olgun HN
    Genet Test Mol Biomarkers; 2016 Feb; 20(2):74-80. PubMed ID: 26790040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complex cytogenetic abnormalities in T-lymphoblastic lymphoma: resolution by spectral karyotyping.
    Wan TS; Ma SK; Chan GC; Ching LM; Ha SY; Chan LC
    Cancer Genet Cytogenet; 2000 Apr; 118(1):24-7. PubMed ID: 10731586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular cytogenetic characterization of Sézary syndrome.
    Mao X; Lillington DM; Czepulkowski B; Russell-Jones R; Young BD; Whittaker S
    Genes Chromosomes Cancer; 2003 Mar; 36(3):250-60. PubMed ID: 12557225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R; Hero B; Simon T; Berthold F
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Next-Generation Sequencing and Fluorescence In Situ Hybridization for Detection of Segmental Chromosomal Aberrations in Neuroblastoma.
    Kim E; Lee B; Lee JW; Sung KW; Kim JS
    Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping.
    Krex D; Mohr B; Hauses M; Ehninger G; Schackert HK; Schackert G
    J Neurooncol; 2001 Apr; 52(2):119-28. PubMed ID: 11508811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity.
    Caron H; van Sluis P; van Roy N; de Kraker J; Speleman F; Voûte PA; Westerveld A; Slater R; Versteeg R
    Am J Hum Genet; 1994 Aug; 55(2):341-7. PubMed ID: 8037211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.
    Mrózek K
    Semin Oncol; 2008 Aug; 35(4):365-77. PubMed ID: 18692687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.